Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is attending ASCO 2018.
  • Written by Admin
  • Written date 2019-01-14 11:36:29
  • Inquire 3644

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine 

is attending ASCO 2018 (https://am.asco.org/).

 

 

For investors attending the ASCO 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management at sungwoo.kim@pharmabcine.com.

List





Prev PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...